7 Drugmakers Drawing a Crowd

The iShares Nasdaq Biotechnology ETF (IBB) is assailing new heights, as biotechs surge again

Jul 15, 2015 at 2:46 PM
facebook X logo linkedin

The major market indexes are looking to extend their winning streaks, though upside momentum is relatively muted compared to the big gains of the past few days. However, one sector that's standing out -- again -- is biotech, with the iShares Nasdaq Biotechnology ETF (IBB) assailing new heights, and a number of drugmakers pacing the Nasdaq leaders. 

IBB was last seen 1.4% higher at $393.27, and earlier notched a record high of $396.94. In the options pits, calls are crossing the tape at twice the average daily pace, with potential buy-to-open action spotted at the July 392.50-, 395-, 397.50-, and 400-strike calls. By purchasing the calls to open, the buyers expect IBB to extend its upward momentum through the end of the week, which represents' the contracts' lifetime.


Digging deeper into the outperformers, PTC Therapeutics, Inc. (NASDAQ:PTCT) is up 7 points, or 14.3%, thanks to a nod from J.P. Morgan Securities. In the same vein, Zogenix, Inc. (NASDAQ:ZGNX) is 2.3 points, or 12.8%, higher -- and earlier hit an annual high of $20.47 -- after a price-target hike to $28 from $20 at Brean Capital. The brokerage firm also waxed optimistic on the company's experimental drug for Dravet syndrome.

Arguably the biggest story of the biotech world today, however, belongs to Celgene Corporation (NASDAQ:CELG) -- up 10.1 points, or 8.2%, and fresh off an all-time peak of $135.98, on news of its $7.3 billion purchase of Receptos Inc (NASDAQ:RCPT).

Enjoying the ride are Celldex Therapeutics, Inc. (NASDAQ:CLDX) and OHR Pharmaceutical Inc (NASDAQ:OHRP). The former is up 1.1 points, or 4.1%, to wink at $27.18, and the latter has added 0.7 point, or 21.5%, to hang just south of $4, extending its data-induced surge sparked earlier this week. Likewise, Esperion Therapeutics Inc (NASDAQ:ESPR) has surged 4.2 points, or 4.6%, to dock at $95.82.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI